Geneoscopy, Inc. develops and commercializes RNA-based diagnostic tests for colorectal cancer and inflammatory bowel disease.

Praia Health develops technology to streamline and personalize the patient lab ordering experience.

PreciseDx is a company that uses AI-driven technology to provide detailed diagnostics and risk assessments for oncology, particularly focusing on breast cancer.

HealthEC is a healthcare technology company that provides an AI-enabled Population Health Management platform to help customers succeed with value-based care by providing comprehensive analytics and integrated tools for care coordination.

AOA Dx is a NYC-based company that has raised $17M in funding to develop a detection test for ovarian cancer using their GlycoLocate™ platform, which focuses on glycolipids and tumor marker gangliosides to improve early cancer detection.

Evvy is a precision women's health startup that provides comprehensive care through state-of-the-art testing and coaching, focusing on the vaginal microbiome to address misdiagnosis and recurrence rates associated with vaginal discomfort, and uncovering links to infertility, STIs, preterm birth, and gynecologic cancers.

Adela is a healthcare technology company that specializes in blood testing for early cancer detection and minimal residual disease monitoring using a genome-wide methylome enrichment platform.